Denis Chem Lab Limited, a manufacturer of parenteral products based in Ahmedabad, Gujarat, has informed BSE Limited of the resignation of its Secretarial Auditors, M/s. Nishant Pandya & Associates, Practising Company Secretaries. The resignation was communicated via a letter dated 6th May, 2026, and takes effect immediately, i.e., from Financial Year 2025-26 onwards. The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III of the Listing Regulations and relevant SEBI Circulars.

Resignation Details

The outgoing Secretarial Auditors, M/s. Nishant Pandya & Associates, cited personal reasons for their resignation. The firm confirmed that there are no other material reasons for the cessation and raised no objection to the appointment of any other Secretarial Auditors by the company. The key disclosure particulars as submitted to the exchange, detailed in Annexure 1 of the filing, are presented below:

Regulatory Compliance

The intimation was submitted by Anal R. Desai, Company Secretary and Compliance Officer of Denis Chem Lab Limited, in accordance with the applicable provisions of the SEBI Listing Regulations. The resignation letter from M/s. Nishant Pandya & Associates was enclosed as an annexure to the filing. The firm, operating under Firm Registration Number S2019GJ700100, confirmed that it is no longer associated with the company in the capacity of Secretarial Auditors for Financial Year 2025-26.

Denis Chem Lab Limited has issued a formal response to the BSE regarding recent movements in its share price, clarifying that no undisclosed material information is driving the price changes. The pharmaceutical company, which specializes in manufacturing parenteral products, addressed the exchange's inquiry through a comprehensive disclosure dated April 10th, 2026.

Company's Official Response

In response to BSE's email reference L/SURV/ONL/PV/APJ/2026-2027/3585 dated April 9th, 2026, Denis Chem Lab Limited provided detailed clarification on the price movement concerns. The company emphasized its commitment to regulatory compliance and transparent disclosure practices.

Regulatory Compliance Statement

The company stated that all material information bearing on operations and performance, including price-sensitive information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has been disclosed within stipulated timeframes. Denis Chem Lab Limited confirmed there is no pending information or announcements that could influence price behavior in the scrip.

Management's Position on Price Movement

The pharmaceutical manufacturer attributed the share price movements to market conditions, stating they are "purely due to market conditions and absolutely market driven." The management clarified that it has no connection with the price movements, emphasizing the market-driven nature of the fluctuations.

Company Background

Denis Chem Lab Limited operates as a manufacturer of parenteral products and holds ISO 9001:2008 certification. The company is incorporated under CIN L24230GJ1980PLC003843 and maintains its registered office in Ahmedabad, Gujarat. The response was digitally signed by Company Secretary and Compliance Officer Anal R. Desai, reinforcing the official nature of the clarification.